World's Best Scientists 2026 revealed!
Philip Scheltens

Philip Scheltens

Award Badge
Best Scientists
2025
Award Badge
Medicine
Netherlands
2023

D-Index & Metrics

Best Scientists

D-Index
172
Citations
164614
World Ranking
788
National Ranking
19

Medicine

D-Index
174
Citations
171379
World Ranking
442
National Ranking
18

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award
  • 2023 - Research.com Medicine in Netherlands Leader Award
  • 2022 - Research.com Medicine in Netherlands Leader Award
  • 2015 - Member of Academia Europaea
  • 2011 - Royal Netherlands Academy of Arts and Sciences

Overview

Philip Scheltens is affiliated with Amsterdam UMC in the Netherlands and specializes in medical research with a focus on dementia and cognitive impairment. Their work prominently covers Alzheimer's disease research and treatments, contributing to advancements in understanding the disease's diagnosis, progression, and underlying mechanisms.

Their research spans several subfields within medicine, including psychiatry and mental health, physiology, cognitive neuroscience, neurology, and molecular biology. This multidisciplinary approach supports comprehensive investigations into brain function, disease biomarkers, and therapeutic strategies.

Philip Scheltens has published extensively in prominent academic journals. Frequent publication venues include:

  • Alzheimer s & Dementia
  • Alzheimer s Research & Therapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neurology
  • Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring

Their notable recent papers feature significant contributions in the field, such as:

  • "Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup" (2024) in Alzheimer s & Dementia
  • "Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias" (2020) in The Lancet Neurology
  • "World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia" (2020) in Alzheimer s & Dementia
  • "The probabilistic model of Alzheimer disease: the amyloid hypothesis revised" (2021) in Nature reviews. Neuroscience
  • "The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease" (2020) in Alzheimer s Research & Therapy

Frequent co-authors in Philip Scheltens' collaborations include Wiesje M. van der Flier, Charlotte E. Teunissen, Frederik Barkhof, Pieter Jelle Visser, and Bart N.M. van Berckel, reflecting ongoing research partnerships that support multidisciplinary studies in neurodegenerative diseases.

The main research topics addressed in their body of work include:

  • Dementia and Cognitive Impairment Research
  • Alzheimer's disease research and treatments
  • Functional Brain Connectivity Studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Genetic Associations and Epidemiology
  • Advanced Neuroimaging Techniques and Applications
  • Nutritional Studies and Diet

Philip Scheltens has received formal recognition such as membership in Academia Europaea since 2015 and election to the Royal Netherlands Academy of Arts and Sciences in 2011, indicating their established status within the scientific community.

Best Publications

  • The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

    Guy M. McKhann;Guy M. McKhann;David S. Knopman;Howard Chertkow;Bradley T. Hyman

  • NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

    Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo

  • Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

    Bruno Dubois;Howard H. Feldman;Claudia Jacova;Steven T. DeKosky

  • Consistent resting-state networks across healthy subjects

    J. S. Damoiseaux;S. A. R. B. Rombouts;F. Barkhof;P. Scheltens

  • The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

    G.M. McKhann;D.S. Knopman;H. Chertkow;B.T. Hyman

  • Mild cognitive impairment

    Serge Gauthier;Barry Reisberg;Michael Zaudig;Ronald C. Petersen

  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

    Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel

  • A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

    Frank Jessen;Frank Jessen;Rebecca E. Amariglio;Martin van Boxtel;Monique Breteler

  • Risk of dementia in diabetes mellitus: a systematic review

    Geert Jan Biessels;Salka Staekenborg;Eric Brunner;Carol Brayne

  • Revising the definition of Alzheimer's disease: a new lexicon.

    Bruno Dubois;Howard H. Feldman;Howard H. Feldman;Howard H. Feldman;Claudia Jacova;Jeffrey L. Cummings

  • The clinical use of structural MRI in Alzheimer disease

    Giovanni B. Frisoni;Nick C. Fox;Clifford R. Jack;Philip Scheltens

  • A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT

    L. O. Wahlund;F. Barkhof;F. Fazekas;L. Bronge

  • Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

    P Scheltens;D Leys;F Barkhof;D Huglo

  • Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

    Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens

  • Defeating Alzheimer's disease and other dementias: a priority for European science and society

    Bengt Winblad;Bengt Winblad;Philippe Amouyel;Sandrine Andrieu;Clive Ballard

  • A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

    Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo

  • Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

    Frederik Barkhof;Massimo Filippi;David H. Miller;Philip Scheltens

  • Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.

    Willemijn J. Jansen;Rik Ossenkoppele;Dirk L. Knol;Betty M. Tijms

  • White matter hyperintensities, cognitive impairment and dementia: an update.

    Niels D. Prins;Philip Scheltens

  • CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

    Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen

Frequent Co-Authors

Wiesje M. van der Flier
Wiesje M. van der Flier Vrije Universiteit Amsterdam
Frederik Barkhof
Frederik Barkhof University College London
Pieter Jelle Visser
Pieter Jelle Visser Amsterdam University Medical Centers
Rik Ossenkoppele
Rik Ossenkoppele Lund University
Kaj Blennow
Kaj Blennow University of Gothenburg
Frans R.J. Verhey
Frans R.J. Verhey Maastricht University
Giovanni B. Frisoni
Giovanni B. Frisoni University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Many students pursuing Medicine in the USA are also interested in related healthcare career paths and online degree programs. These alternative routes can offer flexible study options and a faster track into healthcare careers.

Registered Nurses looking to advance their qualifications may consider an rn to bsn online with no clinicals program, which allows for completion without the need for on-site practicums. For those aiming for the highest level of nursing practice, the fastest online dnp programs provide accelerated options to earn a Doctor of Nursing Practice degree.

Affordability is a common concern, but there are options for the cheapest dnp programs that do not compromise on quality. Those seeking to enter the workforce more quickly might explore an lpn accelerated program, which offers practical nurse training at a faster pace through online learning.

Choosing the right pathway depends on your career goals, time commitment, and financial resources. Online programs continue to expand access, allowing more students to find a healthcare career that fits their lifestyle.

Best Scientists Citing Philip Scheltens

Trending Scientists

Recently Published Articles